Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Summary: Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 in...

Full description

Bibliographic Details
Main Authors: Adrianna Murphy, PhD, Benjamin Palafox, MSc, Owen O'Donnell, ProfPhD, David Stuckler, ProfPhD, Pablo Perel, PhD, Khalid F AlHabib, ProfMBBS, Alvaro Avezum, ProfPhD, Xiulin Bai, BSc, Jephat Chifamba, ProfDPhil, Clara K Chow, ProfPhD, Daniel J Corsi, PhD, Gilles R Dagenais, MD, Antonio L Dans, MD, Rafael Diaz, MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, Roya Kelishadi, MD, Rasha Khatib, PhD, Fernando Lanas, PhD, Scott A Lear, ProfPhD, Wei Li, ProfPhD, Jia Liu, MSc, Patricio Lopez-Jaramillo, ProfPhD, Viswanathan Mohan, ProfMD, Nahed Monsef, PhD, Prem K Mony, MD, Thandi Puoane, ProfDrPH, Sumathy Rangarajan, MSc, Annika Rosengren, ProfMD, Aletta E Schutte, ProfPhD, Mariz Sintaha, MSc, Koon K Teo, ProfPhD, Andreas Wielgosz, ProfMD, Karen Yeates, MD, Lu Yin, PhD, Khalid Yusoff, ProfMBBS, Katarzyna Zatońska, PhD, Salim Yusuf, ProfPhD, Martin McKee, ProfPhD
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X18300317

Similar Items

Similar Items